Search

Objective:To evaluate the effect of combined iron–zinc supplementation on micronutrient status, growth and morbidity.Design:Randomized, double-masked, placebo-controlled supplementation trial.Setting:Rural district of Que Vo, in the Red River Delta in Vietnam.Subjects:A total of 915 breast-fed infants aged 4–7 months were included and 784 completed the study.Interventions:The Fe-group received daily and for a 6-month period 10 mg of iron, the Zn-group 10 mg zinc, the Fe–Zn group 10 mg iron+10 mg zinc and the placebo group a placebo. Hemoglobin (Hb), serum ferritin (SF) and zinc (SZn), and anthropometry were measured before and at the end of the intervention. Morbidity was recorded daily.Results:Changes of Hb and SF were higher in both Fe and Fe+Zn groups (respectively 22.6 and 20.6 g/l for Hb; 36.0 and 24.8 μg/l for SF) compared to Zn and placebo groups (Hb: 6.4 and 9.8 g/l; SF: −18.2 and −16.9 μg/l, P<0.0001). SZn increased more in Zn group (10.3 μmol/l) than in Fe+Zn group (8.0 μmol/l, P=0.03) and more in these groups compared to Fe and placebo groups (1.6 and 1.2 μmol/l, P<0.0001). Weight gain was higher in the Zn group. No significant effects of supplementations on growth in length or morbidity.Conclusions:Combined iron–zinc supplementation had a positive effect on iron and zinc status in infants. However, the positive effect of zinc alone on SZn and weight would indicate a negative interaction of iron when added to zinc supplements.Sponsorship:UNICEF New York.European Journal of Clinical Nutrition (2006) 60, 443–454. doi:10.1038/sj.ejcn.1602336; published online 23 November 2005 [ABSTRACT FROM AUTHOR]

Objective: To assess the impact of a daily oral iron supplementation on hematological status, cell-mediated immunity and susceptibility to infections in children living in an environment where iron deficiency, malaria and other infections are frequent.Design: Randomized, double-blind iron supplementation including a placebo group.Setting: A village in Togo, West Africa.Subjects: Of the 229 6-36-month-old children of both sexes recruited, 197 with hemoglobin concentration >/=80 g/l were included and 163 completed the study.Intervention: Children received daily a placebo (n=79) or a dose of 2-3 mg of elemental iron per kg of body weight (n=84) for 3 months. Hematological, nutritional and immune status were assessed at the beginning and at the end of the supplementation period, and 6 months later. Morbidity was recorded throughout the study.Results: Iron supplementation had a significant and positive effect on iron status of children and no impact on the incidence of infections, especially malaria. Its probable effect on immune status was masked by interference of infections and their treatment, which contributed to improve hematological and immune status in both groups.Conclusion: According to the negative consequences of anemia and iron deficiency on global child development, control of iron deficiency by oral iron supplementation in young children has to be conducted, associated with prophylaxis and treatment of malaria and repeated deworming.Sponsorship: Program supported by IRD. European Journal of Clinical Nutrition (2000) 54, 29-35 [ABSTRACT FROM AUTHOR]